News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
|Articles|April 9, 2021

Strategic Partnerships for Unlocking Product Potential

Author(s)AmerisourceBergen

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

De-Risking Clinical Development: Strategic Multipliers in Global Trials

BySeriant
December 4th 2025

Unlocking Financial and Operational Efficiencies in Clinical Trials: Modern Competitive Advantages in 2025

BySeriant
December 4th 2025

Rethinking Clinical Trial Data in the Era of Decentralization

BySeriant
November 24th 2025

Your DSCSA Responsibilities

By Tecsys
November 12th 2025

DSCSA in the Warehouse: Implications, Opportunities and Best Practices

By Tecsys
November 12th 2025

Trending on PharmExec

1

Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion

2

Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER

3

FDA Appoints Tracy Beth Høeg as Acting Director of CDER

4

FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma

5

Five Steps for Successful CGT Commercialization Through Health Systems Partnerships

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us